Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05023135 · ClinicalTrials.gov registry record
DeepView SnapShot Portable (DV-SSP): Device Training Study
A clinical trial of Burns and Wound Heal, sponsored by SpectralMD.
- Completed
- Registry status
- 251
- Enrollment target
- 11
- Study locations
NCT05023135 is a study of Burns and Wound Heal that has completed, run by SpectralMD. The registered enrollment target is 251 participants, above the 76-participant average among 36 other Burns trials with a reported enrollment target (230% higher). The trial reports 11 study locations across 10 states.
The verdict
NCT05023135, a study of Burns and Wound Heal, has completed, sponsored by SpectralMD.
- COMPLETED
- Registry status
- 251 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this study is to continue development and validation of an algorithm for burn healing assessment by the Spectral MD DeepView device and provide burn healing potential assessment.
Conditions Studied
Interventions
- DEVICE DeepView SnapShot Portable (DV-SSP)
Study Locations (11)
Louisiana
- University Medical Center New Orleans - New Orleans
- Children's Hospital - New Orleans
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- Valleywise Health - Phoenix
Connecticut
- Bridgeport Hospital - Bridgeport
District of Columbia
- MedStar Health Research Institute - Washington D.C.
Massachusetts
- Massachusetts General Hospital - Boston
New York
- Stony Brook Medicine - Stony Brook
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2021-09-07 |
| Est. Completion | 2023-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05023135
The ClinicalTrials.gov registry entry for NCT05023135 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 251 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 76-participant average among 36 other Burns trials with a reported enrollment target (230% higher). The listed sponsor is SpectralMD, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Burns appearing as the primary indexed condition, and to 1 intervention - of which DeepView SnapShot Portable (DV-SSP) is the first listed.
NCT05023135 reports 11 study locations spanning 10 distinct geographic areas - top geographies include Louisiana, Alabama, Arizona.
Frequently Asked Questions
What is clinical trial NCT05023135 about?
NCT05023135 is a clinical study titled "DeepView SnapShot Portable (DV-SSP): Device Training Study". The purpose of this study is to continue development and validation of an algorithm for burn healing assessment by the Spectral MD DeepView device and provide burn healing potential assessment.
What is the current status of trial NCT05023135?
This trial is currently completed. The enrollment target is 251 participants. The study started on 2021-09-07. Estimated completion is 2023-04-30.
What conditions does trial NCT05023135 study?
This clinical trial studies the following conditions: Burns, Wound Heal.
What interventions are being tested in trial NCT05023135?
The interventions under investigation include: DeepView SnapShot Portable (DV-SSP) (DEVICE).
Who is sponsoring clinical trial NCT05023135?
This trial is sponsored by SpectralMD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05023135 being conducted?
This trial has 11 study locations across Alabama, Arizona, Connecticut, District of Columbia, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burns
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds
RECRUITING · NA
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
-
Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers
RECRUITING · Phase 4
-
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
RECRUITING · Phase 4
-
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
RECRUITING · Phase 2
-
Impact of a Telerehabilitation Program With Technology Enhancement on Post-burn Recovery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.